Category: by publisher

Science journal flags cancer paper under investigation for image manipulation

Science Signaling has issued an expression of concern for a 2016 paper, citing an institutional investigation into image manipulation.

According to a spokesperson for the journal, the corresponding author, Tanya Kalin, became concerned that two images in the paper had been manipulated. Kalin then notified the research integrity officer at Cincinnati Children’s Hospital Medical Center, where she is based.

On May 9 2017, Kalin alerted the journal to the investigation. A week later, the hospital’s research integrity officer followed up with the journal, flagging the figures under question.  The journal then prepared an expression of concern (EOC) to alert readers to the issues and the institution’s investigation.  

Here’s the EOC notice for “The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5:” Continue reading Science journal flags cancer paper under investigation for image manipulation

NIH neuroscientist up to 19 retractions

Stanley Rapoport.
Source: NIH

The string of apparent bad luck continues for Stanley Rapoport.

Rapoport, a neuroscientist based at the U.S. National Institute on Aging, has lost three more papers in three journals due to the misconduct of his co-authors. By our count, these retractions bring his tally to 19 — and tie him for 21st place on our leaderboard.

The journals—Schizophrenia Research, Journal of Affective Disorders, and Biological Psychiatry— retracted the papers because the National Institutes of Health had found that one of Rapoport’s co-authors, Jagadeesh Rao, had “engaged in research misconduct by falsifying data.” Rao was corresponding author on all three papers.

According to a spokesperson for Elsevier, which publishes the journals, the Schizophrenia Research paper was retracted in July, the JAD paper in late May and the Biological Psychiatry paper in late April. The spokesperson told us that the publisher first received an email from the NIH about the misconduct findings on September 20, 2016, and that: Continue reading NIH neuroscientist up to 19 retractions

Diabetes researcher who sued to prevent retractions now has 13

A diabetes researcher who sued a publisher to protect several papers from being retracted recently received his 13th, in a prestigious gastroenterology journal.

Mario Saad, based at the University of Campinas in São Paulo, Brazil, has had a string of retractions over the past few years, including four in Diabetes after he lost a legal battle with the American Diabetes Association.

The latest retraction appears in Gastroenterology, citing possible image duplication. Saad is second-to-last author on the 2012 paper.

According to the retraction notice, the journal investigated data in several figures, and believes some were duplicated. The authors explained that the duplications resulted from inadvertently using wrong blots; still, the editors chose to retract the paper after determining they no longer had confidence in its conclusions.  

Here’s the retraction notice for “Obesity-Induced Increase in Tumor Necrosis Factor-α Leads to Development of Colon Cancer in Mice:” Continue reading Diabetes researcher who sued to prevent retractions now has 13

Want to appeal a journal’s rejection? Sure — that’ll be $700

Different journals follow different editorial policies — but we’ve never seen any charge money to authors who want to appeal an editorial decision. Until now.

Recently, a criminal justice researcher sent us links to multiple journals that charge appeal fees. For instance, the Journal of Accounting Research says authors must pay $500 for each submission — and another $500 if they want the journal to reconsider its decision to reject the paper.

Under “Appeals,” the journal writes:

Continue reading Want to appeal a journal’s rejection? Sure — that’ll be $700

Nature Chemistry issues its first retraction

For the first time in its eight-year history, Nature Chemistry has retracted a paper, citing “data integrity issues.”

The 2010 paper, which explored how various iron-based molecules interact with water and ethanol, was withdrawn after the authors uncovered possible duplication in two images.

According to the retraction notice, the authors could not provide the raw data to confirm their findings and could not reproduce the figures because the experimental set-up had been dismantled. The authors subsequently requested the paper be retracted because the issues undermined “our full confidence in the integrity of the study.”

Here’s the retraction notice for “Charge transfer to solvent identified using dark channel fluorescence-yield L-edge spectroscopy”: Continue reading Nature Chemistry issues its first retraction

Nature retracts paper by stem cell scientist appealing her dismissal

Susana Gonzalez

A once-rising star in stem cell biology — who recently lost both her job and a sizable grant — has had a fourth paper retracted.

The notice — issued by Nature for a 2006 letter — cites duplicated images, and a lack of raw data to verify the findings. First author Susana Gonzalez — who was dismissed from her position at the National Center for Cardiovascular Research (CNIC) in Spain last February over allegations of misconduct — couldn’t be reached by the journal.

Here’s the full text of the retraction notice:

Continue reading Nature retracts paper by stem cell scientist appealing her dismissal

“We were devastated:” Authors retract paper after realizing they had used the wrong mice

Raymond Pasek and Maureen Gannon

Longtime readers of Retraction Watch may recall a 2011 post about a research team that retracted a paper after realizing that they had ordered the wrong mice. Maureen Gannon and Raymond Pasek of Vanderbilt University contacted us earlier this week to alert us to a similar case: Their retraction, earlier this month, of a 2016 paper from American Journal of Physiology – Endocrinology and Metabolism after discovering that “a colleague from another lab had mistakenly supplied us with the wrong transgenic mouse line.”

“We strongly believe that sharing this example will encourage other researchers to do the right thing when a mistake is discovered and promote academic integrity,” they wrote. So we asked them to answer a few questions about their experience with “Connective tissue growth factor is critical for proper β-cell function and pregnancy-induced β-cell hyperplasia in adult mice,” a paper that has been cited twice, according to Clarivate Analytics’ Web of Science. 

Retraction Watch: How, and when, did you become aware of the error? Continue reading “We were devastated:” Authors retract paper after realizing they had used the wrong mice

Author “shocked” after top math journal retracts paper

One of the world’s most prestigious mathematics journals has issued what appears to be its first retraction.

The Annals of Mathematics recently withdrew a 2001 paper exploring the properties of certain symmetrical spaces.

What prompted this retraction? And why did it occur 16 years after the paper was published? Continue reading Author “shocked” after top math journal retracts paper

More notices appear for embattled Cornell food researcher

Journals have posted two corrections alongside papers by Brian Wansink, a food researcher whose work has lately come under fire.

One of the corrected papers was among the initial batch that raised eyebrows last year; after Wansink praised the productivity of one of his researchers, critics suggested four papers contained critical flaws. The questions about his work soon extended to other papers, one of which was retracted in April. That month, an internal review by Cornell University announced that Wansink made numerous mistakes, but did not commit misconduct. Wansink has pledged to reanalyze multiple papers.

One paper that was among those initially criticized has received a formal correction notice from the Journal of Product & Brand Management. The notice, which appears behind a paywall, has drawn fire from a regular critic of Wansink’s work, Jordan Anaya, who argues “this correction actually needs a correction, actually several.”

Here’s the notice for “Peak-end pizza: prices delay evaluations of quality:”

Continue reading More notices appear for embattled Cornell food researcher

Lost in translation: Authors blame a language error for wrong diagnosis

A patient’s “unusual” brain cyst excited several researchers in China so much they published a paper about it in a major journal. Soon a reader identified a glaring mistake: the authors had described the cause of the cyst incorrectly.  

A month after the paper appeared online in November 2016, the reader — a neurologist — published a letter in the journal, pointing out the incorrect diagnosis. In their response, the authors acknowledged the mistake but said it had occurred not because they had misdiagnosed the patient, but because the diagnosis had been mistranslated from Chinese to English.

The editors of Neurology retracted the paper because of the error and published a new version with the correct diagnosis on the same day, June 6.

Although we did not hear back from the paper’s two corresponding authors—Jun Guo and Guan Sun—the journal published a string of letters that chronicles the case.

Here’s the retraction (and replacement) notice:  

Continue reading Lost in translation: Authors blame a language error for wrong diagnosis